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This paper aims to present a short history of the 
concept of the development of tumor-host interaction. 
The numerous facets of this concept started to be dis-
cussed in detail quite a long time ago, but especially 
over the last decades and even more so over recent 
years. This topic has received new impetus due to a re-
assessment by scientists of the biological nature 
of tumor growth as well as the appearance of metho-
dological technologies that have allowed the clarifica-
tion of many older findings and the discovery of new 
mechanisms. Especial attention has been devoted 
to these issues by pathophysiologists from Germany, 
Russia and Ukraine who have studied general patho-
logy and, in particular, oncology. The fruitful develop-
ment of Thiersch’s idea has been implemented in the 
works of А. Bogomolets and, especially, by his fol-
lower R. Kavetsky who made a significant contribution 
to the formation of the tumor-host concept.
The 50th anniversary of R. Kavetsky’s monograph 
“Tumor and Host” (Kiev, Gosmedizdat, 1962) which 
was perhaps the first main summary of data on this 
subject is being celebrated in 2012. It is worth noting 
that the special session “Tumor and Host Interrelation-
ships” held within the framework of the VIIIth Interna-
tional Cancer Congress which was held in 1962 in Mos-
cow was organized as a result of Kavetsky’s initiative. 
The plenary lecture given by Kavetsky, together with 
presentations by other scientists and active discus-
sions, provided a special impulse for new investiga-
tions in this field. As part of the celebration of these 
two relevant scientific events, an attempt will be made 
here to familiarize the readers with a short history of the 
tumor-host problem while also presenting some recent 
publications that have focused on the background 
established more than hundred years by prominent 
pathophysiologists of our time.
HISTORICAL PERSPECTIVES
At present it is hard to imagine that at the end 
of the 19th and the beginning of the 20th centuries the 
ideas on the autonomy of tumor growth were shared 
by a number of leading pathologists, among whom Vir-
chow predominated. However, as far back as in 1861, 
the Russian pathologist Pelikan pointed out that 
Virchow’s concept was erroneous and declared that 
a tumor is host-dependent and cannot be autonomous 
in its growth (cited from Ruchkovsky, 1953 [1]). In the 
quest for the truth, it is of interest to recollect that one 
of the known misleading theories, namely that all tu-
mors, including carcinomas — i.e. tumors of epithelial 
origin — are derived from connective tissue, in fact 
belongs to Virchow [2]. Virchow’s claim has been 
opposed and disproved by Cornil, Thiersch and von 
Waldeyer. It was shown that in the case of epithelial 
tumors, cells originate from the existing epithelium. 
The studies of von Waldeyer showed that in their very 
various locations, cancers are, in their origin, con-
nected with epithelial structures (cited from Coats 
and Sutherland [3]). But in the above-mentioned 
studies, an explanation of the mechanisms of tumor 
cell invasion, in particular for cells of epithelial origin 
into adjacent tissues, was absent.
Cohnheim, and in part, Ribbert, suggested that the 
invasion of epithelial tumor cells is only possible when 
an alteration of the connective tissue primarily occurs. 
On the basis of this assumption, the concept that the 
neoplastic growth is determined by tumor stroma was 
formulated. Coats and Sutherland [3] have presented 
the data concerning Thierschґs point of view on the 
cause of cancer, taking into account the differences 
between benign and malignant tumors. In the case 
of benign tumors, normal tissues are able to prevent 
tumor penetration into surrounding tissues, but in the 
case of malignant tumors, adjacent normal tissues 
become unable to form a barrier against tumor expan-
sion. In 1902, Borst summed up the discussion and 
put forward a hypothesis concerning the relationship 
between tumor and stroma [2].
It is possible to imagine that Virchow’s postu-
late partially originated from his own observations 
concerning the stromal, i.e. the connective tissue 
component, of neoplasia. In 1863, Virchow was 
the first to identify leukocytes in the center as well 
as in the periphery of tumor foci, ascertaining that 
the inflammation is one of the predisposing factors 
of tumor development [4]. It should be emphasized 
that Cohnheim, who has been recognized as a pioneer 
of the theory of inflammation, wrote: “There is no in-
flammation without the involvement of blood vessels” 
[4]. Cohnheim explained the presence of leukocytes 
in tumor tissue (characteristic of any inflammatory 
focus) to occur through the migration of polymor-
phonuclear leukocytes from blood vessels supplying 
the tumor. In total, all of the mentioned works have 
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completely overthrown Virchow’s notion which was 
dominating at that time [5].
An assumption concerning the destructive impact 
of a tumor on its host, leading to anemia and general 
weakness and sometimes even to serious constitutio-
nal consequences was made by Coats and Sutherland 
[3]. The authors used terms such as dyscrasia and 
diathesis to designate the state of a body predisposed 
to the initiation and formation of a malignant tumor. 
Nevertheless, direct evidence for such a predisposi-
tion was not available at that time. As early as 1865, 
Thiersch for the first time declared the idea of the role 
of connective tissue in cancer pathogenesis, taking 
into account the ability of the connective tissue to op-
pose the invasion of epithelium (cited from Kavetsky 
[6]). Developing this idea further, Bogomolets pro-
posed the concept of the physiological system of con-
nective tissue. According to his concept, connective 
tissue is of utmost importance in the development 
of many pathological processes including malignant 
growth. Bogomolets noted: “Cancer can hardly arise 
in a body displaying sufficient resistance of the reticu-
lo-endothelial system”. In this respect, he introduced 
the term of “cancer diathesis, i.e. the predisposition 
of an organism to cancer development” which was 
in line with the preceding assumptions of Coats and 
Sutherland. Working actively on this problem, Bogo-
molets arrived at a negation of tumor autonomy, in the 
sense of tumor cells being independent of the host, 
whereby he recognized that metabolic disturbances 
and the reaction of the body are of utmost importance 
for the origin and development of pathological pro-
cesses [7]. It should be emphasized here that he ad-
dressed the problems of the etiology and pathogenesis 
of malignant growth from the point of view that the 
organism should be considered as being one unity and 
can itself be recognized as forming one unit with its 
external environment. At the same time, he supported 
the idea that metabolic disturbances and the reaction 
of the organism are very important in the genesis and 
development of pathological processes.
In Bogomolets’s text-book “Pathological Physio-
logy” (1923), the chapter on tumors contained sub-
chapters devoted to local and more general effects 
of tumors on their host and the reaction of the host 
to tumor development [8]. It is important to note that 
Bogomolets, when considering connective tissue 
as a physiological system, suggested that the internal 
milieu of the organism, with its cellular and non-cellular 
components possesses not only plastic but also tro-
phic and protective functions (cited from Nejman [9]). 
At the same time, Bogomolets considered cancer 
as not being able to develop in a host in which the 
connective tissue exhibits normal resistance proper-
ties [10]. The same idea was almost simultaneously 
declared by a number of French scientists (cited from 
Bogomolets [10]). At that time, much attention had 
been given to the study of connective tissue. The 
active connective tissue, or in the words of Maximov, 
the “mesenchymal reserve” (comprising histiocytes, 
reticulocytes, endothelial cells and hematopoietic 
elements and their derivates, namely leukocytes and 
monocytes, and Hortega cells in the brain) was consi-
dered to be the most powerful system in the organism 
under either physiological or pathological conditions 
[11]. As early as 1909, Ulezko-Stroganova formulated 
a thesis dealing with the significance of connective 
tissue and its customary role in the initiation and deve-
lopment of malignant tumors, explaining the possible 
causes of spontaneous recoveries from cancer [12]. 
At present, the cellular and non-cellular components 
referred to above do in fact mirror the current concept 
of the tumor microenvironment, or more specifically, 
the molecular-cellular microenvironment of tumor 
cells [13–21].
Bogomolets’ ideas on the active mesenchyma be-
ing a factor involved in restraining tumor growth were 
fruitfully further developed by his follower Kavetsky, the 
founder of the Ukrainian School of Oncology. In 1937, 
Kavetsky proposed that: “Two interconnected pro-
cesses comprise the basis of carcinogenesis: (a) the 
local process of carcinogenesis that later develops into 
the real malignant tumor, growing by infiltration, and 
(b) general changes in the body predisposing the pos-
sibility of the primary node being transformed into the 
genuine tumor, with its further dissemination by means 
of metastasis” [6]. This statement comprises the unity 
of processes of malignant transformation of normal 
cells as well as the development of the general disposi-
tion of the organism to tumor growth initiation, “which 
in conjunction promote the development of malignant 
neoplasia in the organism”.
Similar issues were raised by Greenstein 
in 1941 when he contended that “tumor-host interac-
tion is the key to the problem of cancer” (cited from 
Begg [22]). In Begg’s publications from the 1950s, 
many questions concerning tumor-host interac-
tion were discussed. While some of them could not 
be confirmed later, the principal statements still hold 
true at present [22]. According to Begg, the concept 
of “tumor-host interaction” referred to alterations trig-
gered by the tumor in metastasis-free remote tissues 
of the host. In fact, in normal tissues of tumor-bearing 
hosts, some alterations were evident, depending 
on the stage of disease. Initially, such findings con-
cerned several enzymatic systems of the liver and 
spleen. An important observation was that, as a rule, 
tumors contain more nitrogen than that accumulated 
in the tumor-bearing organism, due to a redistribution 
of nitrogen in favor of the tumor and at the expense 
of the host tissues, in particular muscle tissue. Mish-
chenko was apparently the first to carry out careful 
investigations of nitrogen metabolism in animals with 
experimental tumors as well as in cancer patients 
at different stages of the disease [7]. Tumors utilize 
both exogenous and endogenous substances in order 
to meet their own synthetic requirements. Later, Mider 
et al. in 1948 concluded that the tumor-bearing host 
is in the peculiar state of negative nitrogen balance 
and thus designated the tumor as a “trap of nitrogen” 
72 Experimental Oncology 34, 70–74, 2012 (June)
with nitrogen only being lost to the urine (cited from 
Kavetsky [7]).
The pronounced ability of tumors to utilize glucose 
for amino acid synthesis was also discovered. Based 
on the observations of Carrie and Ham (1949), sug-
gesting that tumor growth is accompanied by a de-
creased blood glucose concentration, Begg [22] pro-
posed that malignant tumors must be capable of ex-
tracting glucose from the blood. This idea was further 
developed by Shapot [23, 24] who characterized the 
tumor as being a “trap of glucose”. The biochemical 
changes in the tumor-bearing organism were also 
observed to be accompanied by disturbances in the 
endocrine system, in particular the activation of the 
pituitary-adrenal axis.
In the 1950s and 60s, Kavetsky and his collabora-
tors distinctly outlined the concept of “tumor-host 
interaction”. Having summarized vast amounts 
of experimental and clinical data, Kavetsky [7] stated 
that at first, tumor growth as such is a host reaction 
to a variety of physical, chemical and biological fac-
tors of the environment. In this respect, it is possible 
to accept the definition of the tumor as a “dystrophic 
proliferative reaction of the body to various harmful in-
trinsic and external factors that fundamentally disturb 
the composition and structure of the tissues and cells 
and alter their metabolism” as formulated by Petrov 
[25]. Secondly, an autonomy or independence of tu-
mor growth is out of the question due to the mutual 
relationships between the neoplasm and the host from 
an early stage of tumor formation. At the VIIIth Inter-
national Cancer Congress, Kavetsky summarized the 
principal issues of “tumor-host relationships”, which 
were accepted by almost all oncologists [26, 27]. The 
importance of the above-mentioned problem was con-
firmed by the number of monographs published in the 
following years in which data on the mechanisms and 
different aspects of the tumor-host interaction were 
documented [28–30]. Two scientific conferences, 
entitled “Tumor and Host” and “Tumor and Host Re-
lationship” were held in 1974 and 1980, respectively, 
by the R.E. Kavetsky Institute of Experimental Pa-
thology, Oncology and Radiobiology (IEPOR) of the 
National Academy of Sciences of Ukraine [31, 32].
Two decades later, the rising interest in tumor-host 
relationships on a more up-to-date metho dological 
level was marked by Kerbel’s article published 
in 1995 in the special issue of Cancer and Metastasis 
Reviews [33]. This review highlighted the role of the 
organ and tissue microenvironment in the behavior 
of solid tumors. The scope of the subjects covered was 
very broad and included the biology of intratumoral 
stromal fibroblasts, desmoplastic reactions observed 
in invasive carcinomas, and the ability of stromal cells 
to secrete different matrix metalloproteinases which 
may contribute to metastatic processes. The author 
pointed out that it is important to take tumor-host in-
teractions into account in almost every aspect of tumor 
biology, especially metastasis.
The molecular aspects of tumor-host interaction 
are now the focus of intense research. Liotta and Kohn 
[14] considered the malignant tumor to be a “product” 
of pathological misbalance in the tissue-cell assembly. 
Here, the malignancy may be characterized as a state 
formed in the setting of specific tumor-host relation-
ships at the molecular and cellular microenvironment 
levels when the “host” participates in the induction, 
selection and expansion of neoplastic cells, and in turn 
receives potent impacts generated by the developing 
tumor. From the human viewpoint, the behavior of tu-
mor cells seems to be driven by “their intention not 
to become outcast”. For this reason, they synthesize 
and secrete a variety of stimulating growth factors and 
cytokines, which recruit stromal and other elements 
into the tumor in order to provide the living environment 
appropriate for tumor cells.
In turn, the locally activated “host” microenviron-
ment (cellular and non-cellular components) modifies 
the proliferative and invasive behavior of tumor cells 
resulting generally in an increased aggressiveness 
of the primary tumor and malignant tumor progres-
sion. Zigrino et al. [34] indicated the significant role 
of the interaction of tumor cells with stromal elements 
during tumor progression, focusing on the ability 
of tumor cells to modify the stroma, to change the 
adjacent connective tissue and to modulate the cel-
lular metabolism of the “host”. In this way, stroma 
will be formed which is “most comfortable” for the 
realization of the tumor cell’s aggressive potential. 
The main vital principle of “tumor cell life” may thus 
be characterized as an intention to achieve optimiza-
tion and preservation of the metabolism even at the 
expense of the “host” resources.
The immunological, metabolic, and hormonal 
mechanisms mediated by the nervous system are 
considered as being the “classical” mechanisms 
of tumor-host interaction [35]. It is worth mentioning 
that all of them are very closely connected and that 
their molecular “crosstalk” forms the pathological 
state referred to as tumor disease. Here, the metabolic 
alterations will be briefly discussed to demonstrate 
their impact on immune reactions of the host that are 
of high importance in maintaining tumor-host interac-
tions. As far as a tumor-host relationship involving the 
nervous system is concerned, it should be noted that 
such studies have been considered as being obso-
lete for a number of different reasons. Nevertheless, 
these questions have again been recently brought 
into focus [36].
Pyter et al. [37] verified the hypothesis concern-
ing the ability of the tumor to induce a depression-
like state and to “switch on” the production of both 
peripheral and central anti-inflammatory cytokines. 
Authors have observed increased signs of depressive 
and anxious behavior in rats with induced mammary 
cancer in comparison to that seen in control animals. 
Tumors have been found to produce significantly 
more IL-1β than normal mammary tissue. The levels 
of the inflammatory mediators IL-1β, IL-6 and TNF-α, 
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which provoke behavior similar to depression, as well 
as the anti-inflammatory mediator IL-10 are seen 
to be increased in the hippocampus of rats with mam-
mary carcinoma as compared to control animals. 
In tumor-bearing rats, the level of circulating corti-
costerone inhibiting cytokine signals decreased while 
the expression of genes coding the glucocorticoid 
receptors in the hippocampus increased. The data 
obtained clearly show that tumors are potent induc-
ers of shifts in emotional behavior. The suppression 
of glucocorticoid-related reactions to stress may 
exaggerate the negative effects of tumor-produced 
cytokines in the context of the psycho-emotional 
state of tumor-bearing animals. Based on the data 
concerning tumor cell production of anti-inflammatory 
cytokines capable of inducing depressive behavior 
(anhedonia, anorexia, lethargy), a direct impact of the 
“peripheral” tumor on the hypothalamo-hypophysis-
adrenal axis has been inferred.
Different physiological-biochemical reactions that 
promote the vitality of tumoral as well as normal cells 
form the basis of the metabolic mechanisms of tumor-
host interaction. This aspect of the tumor’s relation-
ship with the host is based on the microenvironment 
of tumor cells which, as it is clear from numerous 
investigations, is the dominant factor in the “tumor-
host” dialogue.
RECENT ACTIVITY
The current problems of tumor-host interactions 
were the subject of the international conference 
entitled “Tumor and Host: Novel Aspects of the Old 
Problem”, that was held on September 21st–24th, 
2010 in Kiev, Ukraine. The meeting was hosted 
by the R.E. Kavetsky ІEPOR and was dedicated to the 
50th Anniversary of the IEPOR. Plenary lectures, pre-
sentations and the general discussion emphasized the 
impact of different aspects of tumor and host interac-
tions and their influence on tumor aggressiveness and 
cancer progression, focusing in particular on immu-
nological aspects of tumor growth, the microenviron-
ment of tumor cells, signaling pathways mediating 
the formation of the biological profile of tumors, and 
new trends in cancer prevention, diagnostics and 
therapy. The issues covered at this conference were 
published together with a meeting report [38, 39]. 
A further noteworthy scientific conference entitled 
“Tumor-Host Interaction and Angiogenesis: Mecha-
nisms and Therapeutic Implication” was also held this 
year in Switzerland [40].
It is very important to underline that at present, the 
interactions between tumor and host mainly concern 
the interactions between tumor cells and stromal cells 
as well as immune cells and bone marrow-derived cells 
that were recruited into the tumor node. It somewhat 
narrows the classic concept of the tumor-host relation-
ship which includes the different organs and systems 
of the body and considers both systemic reactions 
of the organism in addition to responses of stromal 
elements to the tumor.
McAllister and Weinberg [41], while summarizing 
the recent advances in tumor-host relationships de-
clared that many aspects of tumor biology can only 
be explained by a detailed understanding of both local 
and systemic interactions.
One of the manifestations of the systemic interrela-
tionships between the tumor and host can be consid-
ered to be the well-known recruiting of normal cells into 
the tumor by signals from tumor cells that support the 
survival of the neoplasia. It allows a characterization 
of “the сancer as an ecosystem composed of tumor 
cells and of non tumor cells residing in the tumor mi-
croenvironment or recruited to this site” [42]. It was 
recently emphasized that “the original concept that 
cancer cells do not manifest the disease alone, but 
rather conscript and corrupt resident and recruited 
normal cell types to serve as contributing members 
to the outlaw society of cells” [43].
In this aspect, the statement of Goodwin et al. [44] 
that “there is growing evidence that it is necessary 
to go beyond the cell into the whole organism to fully 
understand the biology of cancer and its treatment” 
is very important and highly relevant. It has to be not-
ed that a personalized therapy needs to be rooted 
in a consideration of the reality that any tumor growth 
and progress involves a close interconnection with the 
individual organism, and that the problem of an indi-
vidual patient’s management  may only be successfully 
achieved within the frame of the concept of “tumor-
host interaction”.
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